ARTICLE | Company News
BTG, Paladin sales and marketing update
March 8, 2010 8:00 AM UTC
Paladin received exclusive rights from BTG's Protherics Inc. subsidiary to market DigiFab in Canada. The polyclonal antibody against digoxin (digitalis) glycosides is under review in Canada to treat...